Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol
- PMID: 7767949
- DOI: 10.1007/BF00689197
Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol
Abstract
Taxol is metabolized by the liver microsomal cytochrome P450 enzyme system into its principal metabolite 6 alpha-hydroxytaxol (6HT). In the present in vitro studies 6HT was compared to taxol with respect to its effects on tubulin depolymerization, mitotic arrest, clonogenic survival and apoptosis in HL-60 cells. 6HT was generated by incubating taxol with human liver microsomes in a NADPH-generating system. HL-60 cells were incubated for 24 h with either taxol or 6HT, washed and placed in drug-free suspension or cultured for colony growth in agarose. For the suspension and colony culture growth of the cells, the IC50 concentrations of 6HT were 500 +/- 46 and 350 +/- 37 nM, while those of taxol were 3.2 +/- 0.2 and 2.8 +/- 0.5 nM, respectively. Immediately after a 24-h exposure of HL-60 cells to 50 nM taxol, electrophoresis of genomic DNA from HL-60 cells revealed an internucleosomal DNA fragmentation 'ladder'. In addition, 39% of the cells were arrested in mitosis and 16% showed the morphologic features of apoptosis. In contrast, an identical treatment with 6HT resulted in the mitotic arrest of only 2.8% of the cells, with 4.0% displaying apoptosis (P < 0.01); internucleosomal DNA fragmentation was not observed. 6HT was also significantly less effective than taxol in inhibiting the temperature-induced depolymerization of microtubules in a cell-free system. However, at equipotent concentrations, the effect of 6HT on tubulin depolymerization, mitotic arrest or apoptosis was similar to that of taxol. In addition, at concentrations of taxol or 6HT at or below their IC50, there was little tubulin depolymerization, mitotic arrest or apoptosis. The results presented here show that the biotransformation of taxol to 6HT substantially detoxifies taxol.
Similar articles
-
High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.Leukemia. 1994 Nov;8(11):1960-9. Leukemia. 1994. PMID: 7526093
-
1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.Cancer Chemother Pharmacol. 1994;34(5):365-71. doi: 10.1007/BF00685559. Cancer Chemother Pharmacol. 1994. PMID: 7915211
-
Isolation, structural determination, and biological activity of 6 alpha-hydroxytaxol, the principal human metabolite of taxol.J Med Chem. 1994 Mar 4;37(5):706-9. doi: 10.1021/jm00031a022. J Med Chem. 1994. PMID: 7907372
-
Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences.Cancer Chemother Pharmacol. 1995;36(2):107-14. doi: 10.1007/BF00689193. Cancer Chemother Pharmacol. 1995. PMID: 7767945
-
Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.Cancer Res. 1994 Aug 1;54(15):4026-35. Cancer Res. 1994. PMID: 7913410
Cited by
-
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.Eur J Clin Pharmacol. 2011 Jul;67(7):693-700. doi: 10.1007/s00228-011-1007-6. Epub 2011 Feb 16. Eur J Clin Pharmacol. 2011. PMID: 21327421
-
Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.PLoS One. 2011;6(12):e28321. doi: 10.1371/journal.pone.0028321. Epub 2011 Dec 20. PLoS One. 2011. PMID: 22205945 Free PMC article.
-
Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy Applications.Pharmaceutics. 2020 Apr 30;12(5):411. doi: 10.3390/pharmaceutics12050411. Pharmaceutics. 2020. PMID: 32365861 Free PMC article.
-
Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL.Br J Clin Pharmacol. 2005 Mar;59(3):325-34. doi: 10.1111/j.1365-2125.2004.02325.x. Br J Clin Pharmacol. 2005. PMID: 15752379 Free PMC article.
-
Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.Clin Pharmacokinet. 2005;44(4):349-66. doi: 10.2165/00003088-200544040-00002. Clin Pharmacokinet. 2005. PMID: 15828850 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources